Albemarle Corporation ALB NYSE

Albemarle Corporation (ALB) reported total assets of $16.37B and total liabilities of $6.59B for fiscal year 2025, resulting in total equity of $9.78B.

The company held $1.62B in cash and short-term investments. Total debt stood at $3.3B, with net debt of $1.68B. The Debt-to-Equity (D/E) ratio was 0.34 (conservative).

Current ratio is 2.23, indicating strong short-term liquidity. Interest coverage is 0.5x (weak).

Criteria supported by this page:

• HEALTH (67/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (37/100) — Total assets $16.37B and equity $9.78B support the company's competitive scale
• VALUE (64/100) — Debt-to-Equity 0.34 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 38/100 with 1/7 criteria passed.

LIN

Linde plc

$499.65

-1.81%

SHW

The Sherwin-Williams Company

$333.60

-0.23%

ECL

Ecolab Inc.

$273.13

-0.75%

APD

Air Products and Chemicals, Inc.

$296.63

-0.68%

SQM

Sociedad Química y Minera de Chile S.A.

$88.93

+1.48%

PPG

PPG Industries, Inc.

$110.54

+0.28%

LYB

LyondellBasell Industries N.V.

$73.25

-2.99%

DD

DuPont de Nemours, Inc.

$46.68

-1.01%